Mammoth Biosciences — Startup Profile
CRISPR platform company developing diagnostics and therapeutics
HQ: Brisbane, CA, USA | Founded: 2017 | Employees: 100+ | Stage: Late Stage VC | Website: https://mammoth.bio
About
Mammoth Biosciences harnesses the diversity of nature to discover and develop novel CRISPR systems, building a platform that spans both diagnostics and therapeutics. The company's approach enables it to read and write the code of life across multiple verticals, including point-of-care molecular diagnostics and in vivo gene editing. Founded with close ties to CRISPR pioneer Jennifer Doudna, Mammoth has raised over $218M in venture funding and reached unicorn status in 2021.
The Take
Mammoth Biosciences is a CRISPR platform company leveraging novel gene-editing systems discovered through proprietary bioinformatics to build both diagnostic and therapeutic products, achieving unicorn status in 2021 with a $1B+ valuation.
Key Metrics
- Latest Valuation: $1B+
- Last Round: $150M Series D
- Total Funding: $218M+
- Headcount: 100+
- Founded: 2017
- Est. Runway: 430 months (est.)
Funding Rounds
- Round: $23M (2018-01-01) — Undisclosed
- Round: $45M (2020-01-30) — Undisclosed
- Round: $150M (2021-09-09) — Redmile Group
Key People
- Trevor Martin
- Jennifer Doudna
Key Competitors
- Sherlock Biosciences —
- Editas Medicine —
- Intellia Therapeutics —
- Broad Institute / CRISPR Therapeutics —
Timeline Highlights
- 2021-09-09: Series D / Unicorn
- 2020-01-30: Series B
- 2018-01-01: Series A
- 2017-01-01: Company Founded
Recent News
- Breakout CRISPR platform company Mammoth Biosciences is officially a unicorn (2021-09-09)
- Heavyweight-backed Mammoth raises $45 million for CRISPR R&D (2020-01-30)
Similar Startups
- Solugen — Bio-based chemical manufacturing via a modular enzymatic platform
- Benchling — Unified R&D Cloud for life sciences
- Altos Labs — Cellular rejuvenation programming to reverse disease and transform medicine
- Colossal Biosciences — De-extinction and genetic engineering company resurrecting extinct species
- eGenesis — Genome engineering for human-compatible organ transplants
More Biotech Startups
- Altos Labs — Cellular rejuvenation programming to reverse disease and transform medicine
- Vilya — Computational biotech platform designing novel molecular structures to target disease biology
- Insitro — Machine learning-enabled drug discovery and development platform combining high-throughput biology w
- Colossal Biosciences — De-extinction and genetic engineering company resurrecting extinct species
- eGenesis — Genome engineering for human-compatible organ transplants
Browse: Home | Blog | About | All Startups A-Z | View full profile on StartupWiki